Pharmaceutical Executive
Is Congress harming pharmaceutical research by limiting enforcement of improvement patents?
Robert L. Stoll
Advertisement
Articles by Robert L. Stoll
Advertisement
Latest Updated Articles
- Attacks on Pharmaceutical Improvement Patents
August 21st 2019
Advertisement
Advertisement
Trending on PharmExec
1
Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments
2
Novo Nordisk Launches Multi-Month Subscription Program for Wegovy
3
Merck Enters $838 Million Research & Development Collaboration with Infinimmune
4
How Will MFN’s Effects on Medicare Impact Innovation?
5